Lian Xu

Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer

Shirin Khambata‐Ford, Christopher Harbison, Lowell L. Hart et al. · Journal of Clinical Oncology · 2010 · 268 citations · Full text

Medicine, Oncology, Pharmacology +17

Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer

Linjie Zhao, Gaili Ji, Xiaobing Le et al. · Cancer Research · 2017 · 235 citations

Medicine, Cancer Biology, Oncology +17

Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast Cancer

José Baselga, Milvia Zambetti, Antonio Llombart‐Cussac et al. · Journal of Clinical Oncology · 2008 · 110 citations · Full text

Medicine, Oncology, Pharmacology +17

An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis

Linjie Zhao, Gaili Ji, Xiaobing Le et al. · Oncogene · 2017 · 109 citations

Medicine, Cancer Biology, Oncology +16

The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumor-suppressive immunomodulatory transcripts

Linjie Zhao, Wei Wang, Shuang Huang et al. · Genome biology · 2018 · 96 citations · Full text

Medicine, Molecular Biology, Oncology +17